press releases  axogen inc axgn home about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses news  events press releases axogen in the news events press kit products investors investor relations ir overview news  events news  events press releases axogen in the news ir calendar clinical conferences presentations email alerts company information corporate profile management team ir contacts faq financial information financial information financials financial results stock data stock data current quote charts historical data analyst coverage sec filings sec filings all sec filings annual reports quarterly reports section  filings proxy statements corporate governance corporate governance board of directors board committees governance docs contact the board careers contact for patients science of nerve repair about the nervous system peripheral nerve injuries pni pni map ways to diagnose pni how peripheral nerves repair nerve injuries and treatment options medical glossary resources find a nerve surgeon about axogen about axogen management team board of directors patient stories partners and organizations international about the nerve repair market resources science of nerve repair find a nerve surgeon clinical research educational resources registrations  licenses press releases email alerts be the first to receive the latest news from axogen subscribe to alerts press releases essex woodlands fund ix acquires significant position in axogen inc investment of  million builds company balance sheet provides resources to drive growth and pursue expansion opportunities guido j neels leading international healthcare executive joins board of directors alachua fl – august   – axogen inc nasdaq axgn a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries has sold  registered shares of its common stock to essex woodlands a leading investment firm focused on growthoriented companies in the healthcare sector the sale was completed at a price of  per share generated net proceeds of approximately  million to axogen and represented  of the company’s shares post transaction the company plans to use the resources to drive its current market growth strategies accelerate entering into new nerve repair markets and develop and launch additional nerve repair products this funding also provides additional working capital to strengthen the company’s balance sheet related links pdf release pdf “our partnership with essex woodlands puts axogen in an excellent position to build on the momentum we are generating in the nerve repair market as well as capitalize on our numerous opportunities” said karen zaderej president and chief executive officer of axogen “essex woodlands is a premier longterm focused healthcare investor and through their investment in axogen we now have the resources in place to execute our current business plan as well as fund expansion based on our current operations we believe the investment provides axogen with the resources to achieve positive operating cash flow in addition we gain access to the experience and relationships of the essex woodlands organization as we welcome guido neels to the axogen board of directors we believe he will be an outstanding advisor to axogen as we execute our global growth plans” mr neels an operating partner with essex woodlands based in palo alto ca will join axogen’s board of directors as its eighth member mr neels brings to the axogen board more than  years of experience developing international healthcare businesses prior to joining essex woodlands he served as chief operating officer of guidant corporation currently mr neels serves as the chairman of the board of directors for oraya therapeutics as well as serving on the board of directors for entellus medical inc endologix inc and bioventus llc mr neels holds a business engineering degree from the university of leuven in belgium and a master of business administration degree from stanford university “we are very glad to be a shareholder of axogen and we look forward to supporting karen and the management team to continue axogen’s momentum as the leader of innovative surgical solutions for peripheral nerve injuries” said mr neels “we expect a very successful growth trajectory for the company” about axogen inc axogen nasdaq axgn is a leading medical technology company dedicated to peripheral nerve repair axogen’s portfolio of regenerative medicine products is available in the united states canada and several other countries and includes avance® nerve graft an offtheshelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site axoguard® nerve connector a porcine submucosa extracellular matrix “ecm” coaptation aid for tensionless repair of severed nerves and axoguard® nerve protector a porcine submucosa ecm product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments avance® nerve graft is processed in the united states by axogen axoguard® nerve connector and axoguard® nerve protector are manufactured in the united states by cook biotech incorporated and are distributed worldwide exclusively by axogen axogen maintains its corporate offices in alachua florida and is the parent of its wholly owned operating subsidiary axogen corporation for more information about axogen or to sign up for our news alerts please visit wwwaxogeninccom about essex woodlands with  billion under management essex woodlands is one of the largest and oldest growth equity firms pursuing investments in pharmaceuticals medical devices healthcare services and healthcare information technology since its founding in  essex woodlands has maintained its singular commitment to the healthcare industry and has been involved in the founding investing andor management of over  healthcare companies ranging across sectors stages and geography the team is comprised of  senior investment professionals with offices in palo alto houston new york london and shanghai for more information please see wwwewhvcom  cautionary statements concerning forwardlooking statements  this press release contains forwardlooking statements as defined in the private securities litigation reform act of  these statements are based on managements current expectations or predictions of future conditions events or results based on various assumptions and managements estimates of trends and economic factors in the markets in which we are active as well as our business plans words such as expects anticipates intends plans believes seeks estimates projects forecasts continue may should will variations of such words and similar expressions are intended to identify such forwardlooking statements the forwardlooking statements may include without limitation statements regarding our growth our  revenue estimate product development product potential financial performance sales growth product adoption market awareness of our products data validation our visibility at and sponsorship of conferences and educational events the forwardlooking statements are subject to risks and uncertainties which may cause results to differ materially from those set forth in the statements forwardlooking statements in this release should be evaluated together with the many uncertainties that affect axogens business and its market particularly those discussed in the risk factors and cautionary statements in axogens filings with the securities and exchange commission forwardlooking statements are not guarantees of future performance and actual results may differ materially from those projected the forwardlooking statements are representative only as of the date they are made and except as required by law axogen assumes no responsibility to update any forwardlooking statements whether as a result of new information future events or otherwise contact  evc groupmichael polyvioudoug sherk – investor relations                             mpolyviouevcgroupcom dsherkevcgroupcom released august   ir contacts investor relations axogen inc  progress blvd suite  alachua fl  investorrelationsaxogeninccom transfer agent wells fargo shareowner services po box  st paul mn  t  email alerts be the first to receive the latest news and financial information subscribe quick links corporate presentation fact sheet email alerts ir contacts rss news feed   bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version essex woodlands fund ix lp private company information  bloomberg july    pm et capital markets company overview of essex woodlands fund ix lp snapshot people company overview essex woodlands fund ix lp specializes in growth equity and growth stage the fund seeks to invest in the healthcare sector in the united states  bryant streetrd floorpalo alto ca united statesfounded in  phone  fax  key executives for essex woodlands fund ix lp mr guido j neels managing partner and operating partner age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact essex woodlands fund ix lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft eusa pharma  our investors home about us ▼ company profile ► vision strategy and culture ► management team ► our investors ► board of directors ► products ▼ caphosol® ► collatamp® ► xenazine® ► custodiol® ► pipeline ▼ tivozanib ► dinutuximab beta ► locations current vacancies conditions of sale ▼ uk  polish customers ► german  austrian customers ► french customers ► contact us ▼ corporate headquarters ► customer services ► medical information ► product safety ► research grants ► business development ► our investors essex woodlands with  billion under management essex woodlands is one of the largest and oldest growth equity firms pursuing investments in pharmaceuticals medical devices healthcare services and healthcare information technology since its founding in  essex woodlands has maintained its singular commitment to the healthcare industry and has been involved in the founding investing and  or management of over  healthcare companies ranging across sectors stages and geography the team is comprised of  senior investment professionals with offices in palo alto houston new york london and shanghai china for more information please see wwwewhvcom products caphosol® collatamp® xenazine® custodiol® fomepizole® about us company profile vision strategy and culture management team our investors board of directors contact us corporate headquarters customer services medical information product safety research grants business development other pages home news locations careers copyright  eusa pharma uk ltd  commatic limited   all rights reserved terms of use  privacy statement essex woodlands  investment strategy toggle navigation menu about us investment strategy team portfolio news contact us limited partners investment strategy we back worldclass management teams to lead fastgrowing revenuegenerating healthcare companies we are healthcare specialists this dynamic resilient and growing sector is our passion and our only business us to m in revenues ebitdapositive or soon to be revenue growth drives returns minority or majority positions tell me more we invest broadly across the healthcare spectrum pharmaceuticals  billion worldwide market driven by aging demographics increasing insurance coverage and innovation medical devices  billion worldwide market driven by focus on healthcare outcomes and costs healthcare services largest segment of healthcare industry evolving to deliver quality rather than quantity of care healthcare it fastest growing segment of healthcare sector supported by favorable regulations and need for operational efficiencies global macro trends support healthcare investing change creates opportunities indeveloped markets healthcare is one of the largest segments of the economy at an average  of gdp aging population and chronic diseases are driving healthcare demand knowledge and new technology drive innovation that continues to give rise to new products and companies healthcare companies are increasingly driving revenue growth through acquisitions of smaller faster growing companies growth creates opportunities inemerging markets healthcare is growing at an average  cagr rapidly growing middle class is driving demand for healthcare rapid transfer and adoption of western technology and healthcare products rapid revenue growth and profitability of healthcare companies are generating attractive exits all content    legal disclaimer website by eric miller design essex woodlands  toggle navigation menu about us investment strategy team portfolio news contact us limited partners our portfolio of healthcare investments we partner with worldclass management teams to build bestofbreed businesses view all abiomed produces the impella product line the worlds smallest minimally invasive high performance micro blood pump biotoscana rapidly growing panlatin american specialty pharmaceutical company focused on oncology and critical care drugs bioventus international orthobiologics company focused on bone growth stimulation and joint pain therapies eusa pharma transatlantic specialty pharmaceutical company which focuses on oncology and critical care ew healthcare partners has become a partner and advisor to abiomed and we value the strategic insight and guidance we receive from the team members on various investment and business decisions michael r minogue chairman president and ceo abiomed essex’s deep healthcare expertise industry relationships and strategic insights are helping biotoscana achieve its mission of being the high growth specialty pharma company in latin america mariano garciavalino chief executive officer biotoscana ew healthcare partners challenges our thinking to help us become a better organization plus offers expertise and guidance that helped us emerge from a small spinout company to a global player in the orthobiologics market  anthony p bihl iii chief executive officer bioventus ew healthcare partners is not so much an investor as a partner in building successful businesses as was my experience with eusa bryan morton chief executive officer eusa pharma all content    legal disclaimer website by eric miller design essex woodlands fund ix lp  axogen insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsessex woodlands fund ix lpaxogen axgnten percent owner not rankedessex woodlands fund ix lps performanceessex woodlands fund ix lp has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  axogen axgnmsee the top stocks by insiders  insider rolesaxogen axgn ten percent ownersee the top  corporate insiders  most profitable insider tradestock axogen axgntransaction type informative buydates sep    sep  gain see the latest stocks traded by insiders  essex woodlands fund ix lps trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction dateaxgnaxogenten percent ownerinformative buyundisclosedsep  essex woodlands fund ix lp has not reported any informative transactions for axgn therefore performance cannot be measured track record datetransactionamountno of sharesprice per shareprofitform  sep   informative buy undisclosed   na see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by